(PharmaNewsWire.Com, December 21, 2017 ) According to the report Regenerative Medicines, published by Market Data Forecast, the Europe market is projected to reach USD 5.38 billion by 2021, at a CAGR of 20.50% from 2016 to 2021.
Regenerative medicines repair, regenerate or replace human cells, organs or tissues affected due to injury, disease, congenital defects, aging processes, and damage due to trauma. These medicines reinstate normal functions of tissues and cells. These medicines are available in different forms such as genes, stem cells, somatic cells, and other types. Some of these medicines (such as stem cells) have the ability to differentiate, proliferate, thereby restoring the original structure of cells or organs or tissues. Regenerative medicines are used in various degenerative disorders which include dermatology, cardiovascular, neurodegenerative, and orthopedic diseases, among others. Most of the researchers aim to focus on the development of innovative technologies in order to provide better regenerative medicines and effective healthcare treatment solutions to patients.
Europe Regenerative Medicines: Drivers & Restraints Growing advancements in tissue engineering and stem cell therapy technologies, rising demand for joint and bone reconstructive surgeries, growing adoption of regenerative medicines utilization, presence of huge cell therapy products and increasing number of new product launches in this market among others. However, presence of effective regulations for the usage of cell-based products and stringent regulations for the approval of cell based products are expected to restrain the growth of regenerative medicines market in Europe.
Europe Regenerative Medicines: Overview Factors like rising demand for bone and joint reconstructive surgeries and presence of huge cell therapy products are affecting the growth of this market positively. However, factors such as stringent regulatory pathways and presence of effective regulations for the usage of cell-based products is restraining the growth of this market. Orthopedic & Musculoskeletal spine is estimated to command the largest share of Europe regenerative medicines market by application in 2016.
Europe Regenerative Medicines: Region-wise Outlook The market for Regenerative Medicines in Europe region is divided based on geography into United Kingdom, Germany, Italy, France and Spain. Europe has the second largest market for regenerative medicines in the world by share, after North America region.
Key Questions Answered What is the current and future Regenerative Medicines outlook in Europe market? What trends are affecting the Europe market? What is the competitive landscape and market share of major players in the Regenerative Medicines space in Europe market? What are the key, high growth markets that Regenerative Medicines manufacturers should expand into? Which market segments are growing the fastest? What are the unmet needs with the Regenerative Medicines currently on the market? How will emerging technologies fulfil these unmet needs? What is physician perception and market outlook of Regenerative Medicines? What are the challenges and barriers that have hindered widespread adoption of Regenerative Medicines?
Europe Regenerative Medicines: Key Players Some of the major companies dominating Europe Regenerative Medicines Market are Vertex Pharmaceuticals Incorporated (U.S.), Acelity L.P. Inc. (U.S.), Celgene Corporation (U.S.), StemCells, Inc. (U.S.), Organogenesis Inc. (U.S.), NuVasive, Inc. (U.S.), Vericel Corporation (Genzyme) (U.S.), Japan Tissue Engineering Co., Ltd. (Japan), Cytori Therapeutics Inc. (U.S.), Advantagene, Inc. (U.S.), and Mesoblast Ltd. (Australia).
Reasons to buy Europe Regenerative Medicines Report: Regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Europe Pharmaceuticals Segment:
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
